OD vs. TID Dosing With Mesalazine Granules in Active Ulcerative Colitis

Clinical trial NCT00449722 · COMPLETED

Trial details

NCT number: NCT00449722
Sponsor: Dr. Falk Pharma GmbH
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Ulcerative Colitis

Start date: 2005-07-01
Enrollment: 380

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.